Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Parapharyngeal Space Tumors Treatment & Management

  • Author: Christine G Gourin, MD, FACS; Chief Editor: Arlen D Meyers, MD, MBA  more...
 
Updated: Feb 25, 2015
 

Medical Therapy

Nonoperative management of parapharyngeal space (PPS) lesions may be considered for patients who are poor surgical candidates because of comorbid disease; those who are elderly; those who fail balloon occlusion; those who have unresectable lesions; and those who have benign, slow-growing tumors that would carry a significant risk of sacrifice of multiple cranial nerves if resected. The risks and benefits of surgery must be weighed in every case. The risk of neurovascular complications, including cranial nerve injury and stroke, is increased in patients with paragangliomas and malignancies. Alternatives to surgical therapy consist of observation or radiation therapy.

The risks of observation of benign tumors of the parapharyngeal space (PPS) are continued growth and malignant degeneration. Most prestyloid lesions can be removed with minimal morbidity. Observation is an acceptable alternative in patients in whom the risks of surgery are greater than not operating. This group consists of patients who are poor surgical candidates and patients who are elderly who have paragangliomas that do not produce symptoms. The mortality rate of untreated paragangliomas is less than 10% per year. Paragangliomas have a slow growth rate, estimated at 1.0-1.5 mm per year.

In young patients who are asymptomatic, resection is recommended to avoid future loss of cranial nerve function as the tumor enlarges and to attempt to preserve the nerve of origin, which is far more likely to be successful with a small tumor than a larger one. Patients with partial cranial nerve deficits may initially be observed for 6-12 months to allow compensation to occur because functional compensation to a gradual loss of function is greater than sudden loss of function.

Observation may be appropriate in patients with multiple paragangliomas who have preexisting contralateral cranial nerve deficits resulting from resection of a contralateral paraganglioma. Patients who are elderly do not fare as well following loss of CN function, and the natural course of a paraganglioma that is not producing symptoms may be associated with less morbidity than the morbidity associated with surgical resection.

Radiation therapy can be used as a primary treatment modality in patients with paragangliomas who are poor surgical candidates and in the treatment of malignancies of the parapharyngeal space (PPS). Radiation is not used for cure in the management of paragangliomas because the chief cells of paragangliomas are not radiosensitive, but it may be used to arrest or slow the growth of these lesions by causing endarteritis and fibrosis. Radiation therapy may be considered in those patients who are poor surgical candidates but who require treatment. These include symptomatic patients who are elderly, patients with internal carotid artery involvement in whom balloon occlusion fails, and patients with contralateral cranial nerve deficits in whom resection would result in a significant reduction in quality of life. Radiation therapy is used as an adjunct to surgery in patients with high-grade malignancies and when an oncologic or adequate resection margin cannot be obtained.

Next

Surgical Therapy

Surgery is the mainstay of treatment for tumors of the parapharyngeal space (PPS). The choice of surgical approach is dictated by the size of the tumor, its location, its relationship to the great vessels, and the suspicion of malignancy.

In the aforementioned literature review by Riffat et al of parapharyngeal space (PPS) tumor studies (1143 tumors total), the investigators found that 95% of patients underwent surgery, with the cervical approach being the most frequently used technique (48%). The most common complication, vagus nerve injury, occurred in 14% of cases.[2]

A retrospective study by Prasad et al indicated that benign parapharyngeal space (PPS) tumors can be effectively managed with a lateral skull base approach, which, according to the investigators, offers excellent exposure and reduced morbidity. Transcervical, transcervical-transparotid, transcervical-transmastoid, and infratemporal fossa approaches were used, with 46 of 48 tumors (96%) undergoing total radical removal.[3]

Previous
Next

Preoperative Details

Surgical morbidity can be minimized, or at least anticipated, with careful attention to preoperative evaluation so that both the surgeon and the patient are adequately prepared.

The relationship of the tumor to the great vessels should be clearly delineated by preoperative imaging prior to planning resection, and patients should be counseled accordingly. Injury to the great vessels may result in uncontrollable bleeding, stroke, or death. Consult a vascular surgeon if a possibility of carotid resection requiring interposition grafting exists. Consulting a neurosurgeon may be appropriate for lesions involving the skull base.

Counsel patients preoperatively about the possibility of loss of CN function and the effects on speech and swallowing. Injury or sacrifice of the vagus nerve alone may initially be managed expectantly to determine the effect on function and the final position of the vocal cord; this is done before proceeding with vocal cord medialization at a subsequent date because many patients compensate for an isolated deficit to a significant degree. Injury to both the vagus and the hypoglossal nerves can be expected to significantly impair swallowing function. In this circumstance, perform a cricopharyngeal myotomy and tracheostomy along with thyroplasty or Teflon injection concomitant with resection.

If multiple CN deficits are anticipated, plans may be made for gastrostomy tube placement concomitant with resection if the patient's underlying status suggests that swallowing rehabilitation will be prolonged. Parotidectomy or mandibulotomy may need to be performed intraoperatively for improved exposure; this, as well as the possibility of tracheostomy if mandibulotomy is required, should be discussed with the patient.

Preoperative embolization of vascular lesions may decrease intraoperative blood loss and may facilitate dissection of tumors at the skull base by causing retraction. Embolization is recommended for vascular lesions greater than 3 cm in which obvious feeding vessels can be identified on angiography. The use of embolization of paragangliomas is more controversial. Glomus vagale tumors rarely have a single blood supply, and resection is not associated with excessive blood loss. Carotid body tumors are supplied by the adventitia of the carotid rather than an obvious dominant feeding vessel. Embolization of a carotid body tumor may cause an inflammatory response that may obscure the subadventitial plane in which the tumor is dissected, increasing the risk of inadvertent carotid injury during resection. Embolization carries a risk of possible disruption of the blood supply to cranial nerves. If embolization is performed, it is performed within 24 hours prior to resection.

Functioning tumors must be identified prior to resection because manipulation of a catecholamine-secreting tumor may cause intraoperative cardiac arrhythmias and hypertensive crisis. Preoperatively, institute alpha- and beta-adrenergic blockade with phenoxybenzamine and propranolol. Patients with multiple paragangliomas should undergo preoperative CT scanning of the adrenal glands to search for an associated pheochromocytoma.

Previous
Next

Intraoperative Details

Transoral approach

The transoral approach has been described for the removal of small, benign neoplasms that originate in the prestyloid parapharyngeal space (PPS) and manifest as an oropharyngeal mass. The limitations of this approach are limited exposure, inability to visualize the great vessels, and an increased risk of facial nerve injury and tumor rupture. This approach is best suited for small, benign salivary tumors arising from minor salivary glands of the lateral pharyngeal wall. The transoral approach may be combined with an external approach to mobilize lesions with a significant oropharyngeal component. This is not the approach of choice for most lesions of the parapharyngeal space (PPS).

Transcervical approach

Most authors prefer the transcervical approach as the method for removal of most poststyloid parapharyngeal space (PPS) tumors. A transverse incision at the level of the hyoid bone, 2 fingerbreadths below the mandible, is performed, and the carotid artery and internal jugular vein are identified. The digastric and stylohyoid muscles are retracted to allow access to the parapharyngeal space (PPS). The submandibular gland can be retracted anteriorly for exposure, or it can be removed if necessary.

Transcervical-transparotid approach

For tumors arising from the deep lobe of the parotid, the transcervical approach can be combined with a transparotid approach by extending the incision superiorly as for parotidectomy. The facial nerve is identified and dissected, superficial parotidectomy is performed, and the deep lobe portion of the tumor is identified. The cervical incision allows access to the parapharyngeal space (PPS) component of the tumor.

Transcervical-transmandibular approach

The transcervical approach may be combined with mandibulotomy when better exposure is required. Such situations include very large tumors, vascular tumors with superior parapharyngeal space (PPS) extension, malignancies in which better exposure facilitates oncologic resection, and cases in which distal control of the carotid at the skull base is required. Mandibulotomy may be lateral or anterior (midline); an osteotomy anterior to the mental foramen is preferred for preservation of inferior alveolar nerve function. A lip-splitting incision is used to expose the mandible for midline osteotomy. After mandibulotomy, the incision is continued intraorally along the floor of the mouth back to the level of the tonsil pillar, and the mandible is retracted laterally. Tracheostomy is required for airway management in the immediate postoperative period.

Infratemporal fossa approach

A preauricular infratemporal fossa approach, as described by Fisch, can be used for malignant tumors involving the skull base or jugular foramen. This approach can be combined with frontotemporal craniotomy for removal of tumors with significant intracranial extension. A parotidectomy incision with cervical extension as described above is extended superiorly into a hemicoronal scalp incision. The temporalis muscle is elevated to expose the glenoid fossa, which is removed laterally. The temporomandibular joint can be displaced inferiorly, or the mandible condyle can be transected for improved exposure. Orbitozygomatic osteotomies are performed, and the infratemporal skull base and distal carotid are exposed. The facial nerve and vascular structures in the neck are identified through the cervical and preauricular approaches.

Previous
Next

Postoperative Details

Always perform tracheostomy in conjunction with a transmandibular approach because significant upper airway edema may result from surgical manipulation of the oral cavity and oropharynx, causing obstruction. Bleeding may also cause airway obstruction because of the proximity of the parapharyngeal space (PPS) to the pharynx. Pay careful attention to hemostasis, and closely monitor all patients in the immediate postoperative period.

All patients should be managed with closed suction drains because the dead space resulting from removal of parapharyngeal space (PPS) tumors may result in seroma formation. The risk of infection is greater if a transoral approach is used or combined with a cervical approach, and patients with oral contamination should be administered broad-spectrum perioperative antibiotics.

Injury to the facial nerve may be temporary, from traction injury, or permanent, if the nerve is inadvertently sacrificed or injured. Eye protection with artificial tears, a moisture chamber, and Lacri-Lube ointment is required in these cases in order to prevent corneal exposure and abrasion.

Cranial nerve palsies may result from removal of poststyloid parapharyngeal space (PPS) lesions. The vagus nerve is the most commonly injured nerve. An isolated unilateral vagal injury is usually well tolerated in the otherwise healthy patient, but a high vagal injury or a vagal injury combined with injury to CN IX and XII may result in significant problems with swallowing and aspiration. Patients should be carefully evaluated prior to the institution of oral feedings, and an alternate method of feeding (eg, nasogastric tube, gastric tube) should be instituted if necessary. Tracheostomy may be required for airway protection if multiple cranial nerve deficits result from resection.

Cerebrospinal fluid leaks may occur after removal of tumors with jugular foramen or intracranial extension and result in meningitis. Pay careful attention to the dural closure after tumor removal. Fascia, fat, or muscle can be used to reinforce the closure if necessary. Lumbar drainage is instituted for small leaks; large leaks or those leaks refractory to lumbar drainage require reoperation.

Previous
Next

Follow-up

All patients with parapharyngeal space (PPS) masses should undergo routine follow-up, regardless of whether treatment is nonoperative or surgical. The frequency of follow-up examinations varies according to the tumor histology. Patients treated nonoperatively should be monitored for tumor growth and development or progression of symptoms. Following surgical excision, patients with benign histology are routinely monitored to rule out recurrence. Patients with malignancies require closer observation and monitoring. Adjunctive radiation therapy is appropriate for high-grade malignancies and in cases in which an adequate resection margin cannot be obtained.

Previous
Next

Complications

In addition to the postoperative complications discussed above, injury to the lingual and hypoglossal nerves may result from the transcervical approach when the submandibular triangle is entered. Warn patients preoperatively that injury to any or all branches of the facial nerve may result from nerve resection or traction injury and also that the ramus mandibularis branch is at risk during cervical approaches. Intraoperative transection of the facial nerve is best managed by performing nerve grafting at the time of surgery. Eye protection (as mentioned above) is required in the postoperative period; insertion of a gold weight can be performed at surgery or postoperatively. Facial reanimation procedures may be required for unrecognized facial nerve injury that does not resolve.

Injury to CN IX, X, XI, and XII and the cervical sympathetic chain may result from surgery of the parapharyngeal space (PPS). The risk of postoperative cranial nerve deficits ranges from 11-57%, with higher frequencies observed in studies of patients with proportionately greater numbers of malignancies or neurogenic lesions. An isolated nerve injury is usually well tolerated in an otherwise healthy patient.

Isolated injury to the hypoglossal nerve does not usually significantly impair swallowing or speech function. Injury to the vagus nerve results in vocal cord paralysis, and if injury occurs above the level of the nodose ganglion, laryngeal sensation is also affected. Thyroplasty or Teflon injection may be performed intraoperatively or at a later date. The advantage to delaying vocal cord medialization procedures is that patients will often compensate, and the extent of medialization required can be better assessed after this has occurred.

Patients who are elderly or patients with multiple CN deficits are expected to have greater difficulty with swallowing, and medialization as well as cricopharyngeal myotomy should be performed concomitant with resection. If swallowing rehabilitation is prolonged or unsuccessful, gastrostomy tube placement may be necessary. Patients with difficulty handling oral secretions may require tracheostomy for airway protection.

Injury to the spinal accessory nerve results in weakness of the trapezius muscle, winging of the scapula, and adhesive capsulitis from disuse. This can be managed postoperatively by an active range of motion physical therapy program. When recognized intraoperatively, transection of CN XI is best managed by nerve grafting to achieve some recovery of function. Horner syndrome may result from injury to the cervical sympathetic chain. The resulting anhydrosis is managed symptomatically.

Vascular complications are more common with removal of neurogenic or vascular lesions. The prevalence of intraoperative vascular injury and of perioperative stroke has been reported at 4% for poststyloid lesions. Morbidity may be reduced by avoidance of undue traction on the carotid artery, which may result in intimal tears. Primary repair or vein grafting should be performed for all vessel lacerations.

Complications of mandibulotomy include infection, temporomandibular joint dysfunction, nonunion, plate extrusion, and tooth loss. When the osteotomy site is through dental sockets rather than between them, tooth loss is more common. Malocclusion may occur following mandibulectomy in dentate patients.

Complications of radiation therapy, whether used primarily or as an adjunct to surgery, include xerostomia, tissue fibrosis, acceleration of dental caries, and osteoradionecrosis. Osteoradionecrosis is managed by debridement, antibiotics for secondary infection, and hyperbaric oxygen when it is available. Dental caries may be prevented by the use of fluoride trays. Teeth in poor condition should be extracted. Xerostomia is a life-long problem, but it can be alleviated by treatment with pilocarpine (Salagen, 5 mg PO tid) or artificial saliva applications.

Previous
Next

Outcome and Prognosis

The recurrence rate of benign parapharyngeal space (PPS) neoplasms following surgical extirpation ranges from 0-9%. Paragangliomas recur in approximately 5% of cases, and because 10% are multicentric, the risk of developing a second tumor remains. Patients with a familial paraganglioma syndrome have a 35% risk of multicentricity. In addition, patients with paragangliomas who are being treated nonoperatively must be alerted to the risk of malignant degeneration, which is approximately 10% and usually associated with rapid growth.

Thus, patients with paragangliomas require lifetime follow-up. Malignant tumors of the parapharyngeal space (PPS) have a much higher rate of recurrence (25-77%), depending on histology, extent of resection, and duration of follow-up. Postoperative radiation therapy for parapharyngeal space (PPS) malignancies is recommended to prevent recurrence; however, because of the relative scarcity of these lesions, no large series are available to demonstrate a survival benefit.

Previous
Next

Future and Controversies

In the future, genetic screening of patients at risk for hereditary paragangliomas should be possible. The gene responsible for transmission of hereditary paragangliomas, termed PGL, has been mapped to chromosome 11. In large pedigree analyses, loci at 11q23 (PGL1) have been shown to be most commonly associated with a mutant PGL gene, which is inherited from carrier fathers in an autosomal dominant fashion subject to maternal imprinting. No affected offspring from affected mothers are documented. Genetic manipulation of a mutant PGL gene may prevent or interrupt the development of these tumors.[4]

Previous
 
Contributor Information and Disclosures
Author

Christine G Gourin, MD, FACS Associate Professor, Director of Clinical Reasearch Program in Head and Neck Cancer, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine

Christine G Gourin, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, Phi Beta Kappa, Society of University Otolaryngologists-Head and Neck Surgeons, Association of Women Surgeons, Triological Society, American College of Surgeons Oncology Group

Disclosure: Nothing to disclose.

Coauthor(s)

Jonas T Johnson, MD, FACS Chairman, Department of Otolaryngology, The Eugene N Myers, MD, Professor and Chairman of Otolaryngology, Professor, Department of Radiation Oncology, University of Pittsburgh School of Medicine; Professor, Department of Oral Maxillofacial Surgery, University of Pittsburgh School of Dental Medicine

Jonas T Johnson, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Association for Cancer Research, American Bronchoesophagological Association, American College of Surgeons, American Head and Neck Society, American Laryngological Association, The Triological Society, American Medical Association, American Rhinologic Society, Allegheny County Medical Society, American Society of Clinical Oncology, Pennsylvania Medical Society, Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Erik Kass, MD Chief, Department of Clinical Otolaryngology, Associates in Otolaryngology of Northern Virginia

Erik Kass, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Association for Cancer Research, American Rhinologic Society

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;SymbiaAllergySolutions<br/>Received income in an amount equal to or greater than $250 from: Symbia<br/>Received from Allergy Solutions, Inc for board membership; Received honoraria from RxRevu for chief medical editor; Received salary from Medvoy for founder and president; Received consulting fee from Corvectra for senior medical advisor; Received ownership interest from Cerescan for consulting; Received consulting fee from Essiahealth for advisor; Received consulting fee from Carespan for advisor; Received consulting fee from Covidien for consulting.

Additional Contributors

William M Lydiatt, MD Professor and Division Director, Head and Neck Surgical Oncology, Department of Otolaryngology-Head and Neck Surgery, University of Nebraska Medical Center

William M Lydiatt, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, Nebraska Medical Association

Disclosure: Nothing to disclose.

References
  1. Suarez-Fente V, Llorente-Pendas JL, Gomez-Martinez J, Garcia-Gonzalez LA, Lopez-Alvarez F, Suarez-Nieto C. [Primary tumours of the parapharyngeal space. Our experience in 51 patients.]. Acta Otorrinolaringol Esp. 2009 Jan. 60(1):19-24. [Medline].

  2. Riffat F, Dwivedi RC, Palme C, et al. A systematic review of 1143 parapharyngeal space tumors reported over 20 years. Oral Oncol. 2014 May. 50(5):421-30. [Medline].

  3. Prasad SC, Piccirillo E, Chovanec M, et al. Lateral skull base approaches in the management of benign parapharyngeal space tumors. Auris Nasus Larynx. 2014 Sep 27. [Medline].

  4. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet. 1997 Jan. 60(1):121-32. [Medline].

  5. Batsakis JG, Sneige N. Parapharyngeal and retropharyngeal space diseases. Ann Otol Rhinol Laryngol. 1989 Apr. 98(4 Pt 1):320-1. [Medline].

  6. Carrau RL, Myers EN, Johnson JT. Management of tumors arising in the parapharyngeal space. Laryngoscope. 1990 Jun. 100(6):583-9. [Medline].

  7. Chang SS, Goldenberg D, Koch WM. Transcervical approach to benign parapharyngeal space tumors. Ann Otol Rhinol Laryngol. 2012 Sep. 121(9):620-4. [Medline].

  8. Christopoulos E, Carrau R, Segas J, Johnson JT, Myers EN, Wagner RL. Transmandibular approaches to the oral cavity and oropharynx. A functional assessment. Arch Otolaryngol Head Neck Surg. 1992 Nov. 118(11):1164-7. [Medline].

  9. Cohen SM, Burkey BB, Netterville JL. Surgical management of parapharyngeal space masses. Head Neck. 2005 Aug. 27(8):669-75. [Medline].

  10. Curtin HD. Separation of the masticator space from the parapharyngeal space. Radiology. 1987 Apr. 163(1):195-204. [Medline].

  11. Eisele DE, Netterville JL, Hoffman HT, Gantz BJ. Parapharyngeal space masses. Head Neck. 1999 Mar. 21(2):154-9. [Medline].

  12. Gluckman J. Parapharyngeal space. Gluckman J, Gullane P, Johnson J, eds. Practical Approach to Head and Neck Tumors. New York, NY: Raven Press; 1994. 33-46.

  13. Hamza A, Fagan JJ, Weissman JL, Myers EN. Neurilemomas of the parapharyngeal space. Arch Otolaryngol Head Neck Surg. 1997 Jun. 123(6):622-6. [Medline].

  14. Hughes KV 3rd, Olsen KD, McCaffrey TV. Parapharyngeal space neoplasms. Head Neck. 1995 Mar-Apr. 17(2):124-30. [Medline].

  15. Langerman A, Rangarajan SV, Athavale SM, Pham MQ, Sinard RJ, Netterville JL. Tumors of the cervical sympathetic chain-Diagnosis and management. Head Neck. 2012 Sep 24. [Medline].

  16. Leonetti JP, Donzelli JJ, Littooy FN, Farrell BP. Perioperative strategies in the management of carotid body tumors. Otolaryngol Head Neck Surg. 1997 Jul. 117(1):111-5. [Medline].

  17. McCaffrey TV, Meyer FB, Michels VV, Piepgras DG, Marion MS. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1994 Nov. 120(11):1211-6. [Medline].

  18. Myers EN, Johnson JT, Curtin HD. Tumors of the Parapharyngeal Space. Myers EN, Suen JY, eds. Cancer of the Head and Neck. 3rd ed. Philadelphia, Pa: WB Saunders; 1996. 562-585.

  19. Olsen KD. Tumors and surgery of the parapharyngeal space. Laryngoscope. 1994 May. 104(5 Pt 2 Suppl 63):1-28. [Medline].

  20. Pensak ML, Gluckman JL, Shumrick KA. Parapharyngeal space tumors: an algorithm for evaluation and management. Laryngoscope. 1994 Sep. 104(9):1170-3. [Medline].

  21. Pitman KT, Weissman JL, Johnson JT. The parapharyngeal space: diagnosis and management of commonly encountered entities. Self-instructional package (SIPac). 3rd ed. Rochester, NY: The American Academy of Otolaryngology-Head and Neck Surgery Foundation; 1998. 1-66.

  22. Saito DM, Glastonbury CM, El-Sayed IH, Eisele DW. Parapharyngeal space schwannomas: preoperative imaging determination of the nerve of origin. Arch Otolaryngol Head Neck Surg. 2007 Jul. 133(7):662-7. [Medline].

  23. Schwaber MK, Glasscock ME, Nissen AJ, Jackson CG, Smith PG. Diagnosis and management of catecholamine secreting glomus tumors. Laryngoscope. 1984 Aug. 94(8):1008-15. [Medline].

  24. Som PM, Biller HF, Lawson W. Tumors of the parapharyngeal space: preoperative evaluation, diagnosis and surgical approaches. Ann Otol Rhinol Laryngol Suppl. 1981 Jan-Feb. 90(1 Pt 4):3-15. [Medline].

  25. Som PM, Curtin HD. Lesions of the parapharyngeal space. Role of MR imaging. Otolaryngol Clin North Am. 1995 Jun. 28(3):515-42. [Medline].

  26. Urquhart AC, Johnson JT, Myers EN, Schechter GL. Glomus vagale: paraganglioma of the vagus nerve. Laryngoscope. 1994 Apr. 104(4):440-5. [Medline].

 
Previous
Next
 
Parapharyngeal space tumor manifesting as an oropharyngeal mass.
Parapharyngeal space tumor manifesting as a neck mass.
CT scan of prestyloid space mass. The lesion causes medial displacement of the parapharyngeal fat pad and represents a benign salivary gland tumor.
T2-weighted MRI of a prestyloid space mass. This mass is confluent with the deep lobe of the parotid gland; the parapharyngeal fat pad is displaced medially. These findings are consistent with an origin from the deep lobe of the parotid.
CT scan of a poststyloid space mass. Note the anterior and lateral displacement of the parapharyngeal fat, characteristic of poststyloid lesions. This lesion enhances and proved to represent a carotid body tumor.
MRI of a poststyloid mass. Note anterior displacement of the parapharyngeal fat and multiple flow voids within the tumor itself, consistent with a diagnosis of paraganglioma.
Angiogram of carotid body tumor. These are found between the carotid bifurcation and cause splaying of the internal carotid artery and external carotid artery resulting in the lyre sign.
Angiogram of glomus vagale tumor. Because the vagus nerve lies laterally and posteriorly to the carotid system, these appear as vascular lesions displacing the internal carotid artery and external carotid artery anteriorly and medially.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.